1Pharmacology department, Faculty of Medicine, Zawia University, Lybia
2Pharmacology and toxicology department, Faculty of Pharmacy, Helwan University, Egypt
3Pharmacology department, Faculty of Medicine, Tanta University, Egypt
Journal of Cancer Research and Treatment.
2016,
Vol. 4 No. 2, 26-31
DOI: 10.12691/jcrt-4-2-2
Copyright © 2016 Science and Education PublishingCite this paper: Almokhtar A. Adwas, Abeer A. Elkhoely, Ahmed M. Kabel, Mohamed Nabih Abdel-Rahman, Amany A. Eissa. Ameliorative Potential of Different Doses of Indol-3-carbinol on Doxorubicin-induced Cardiotoxicity in Mice.
Journal of Cancer Research and Treatment. 2016; 4(2):26-31. doi: 10.12691/jcrt-4-2-2.
Correspondence to: Ahmed M. Kabel, Pharmacology department, Faculty of Medicine, Tanta University, Egypt. Email:
drakabel@gmail.comAbstract
Background: Doxorubicin (DOX) is a commonly used chemotherapeutic agent that is associated with serious dose-limiting cardiotoxicity. This cardiotoxicity was attributed to various mechanisms including induction of oxidative stress and inflammation together with inhibition of apoptosis. Indole-3-carbinol (I3C) is a phytochemical that was suggested to have potent anti-oxidant and anti-inflammatory properties. Aim: It was to detect the possible ameliorative effects of different doses of I3C on doxorubicin-induced cardiotoxicity in mice. Methods: Eighty mice were divided into four equal groups: control untreated group; DOX group; DOX + I3C 1000 ppm group and DOX + I3C 2000 ppm group. Survival rate, serum creatine kinase (CK-MB), lactate dehydrogenase (LDH) and troponin I were measured. Also, tissue malondialdehyde (MDA), tissue catalase (CAT), tissue glutathione peroxidase (GPx), and tissue tumor necrosis factor alpha (TNF-α) were determined. Parts of the heart were subjected to histopathological examination. Results: I3C produced dose-dependent significant increase in the survival rate, tissue GPx and CAT with significant decrease in serum CK-MB, LDH, troponin I, tissue MDA and TNF-α and improved the histopathological and immunohistochemical changes compared to DOX-treated group. Conclusion: I3C- in a dose dependent manner- had a protective effect against doxorubicin-induced cardiotoxicity in mice.
Keywords